Status:
COMPLETED
Relation of Circulating Endothelium-derived Microparticle to Carotid Atherosclerosis
Lead Sponsor:
Kurume University
Conditions:
Atherosclerosis
Eligibility:
All Genders
20+ years
Brief Summary
The investigators hypothesized that circulating endothelium-derived microparticle (EMP) may be a useful surrogate marker of atherosclerosis and future episode of cerebrovascular events. Peripheral blo...
Eligibility Criteria
Inclusion
- Patients who undergo carotid ultrasound examination for screening of atherosclerosis
Exclusion
- Cerebrovascular events within the last 12 months
- Acute coronary syndrome, coronary and peripheral intervention within the last 6 months
- Uncontrolled heart failure
- Other severe systemic diseases
Key Trial Info
Start Date :
November 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2013
Estimated Enrollment :
154 Patients enrolled
Trial Details
Trial ID
NCT00795067
Start Date
November 1 2008
End Date
November 1 2013
Last Update
March 31 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kurume University Hospital
Kurume, Fukuoka, Japan, 830-0011